Dimeric quaternary structure of human laforin

Journal of Biological Chemistry

Volumn 290, Issue 8, 2015, Pages 4552-4559

  Sankhala, Rajeshwer S ^a   Koksal, Adem C ^b   Ho, Lan ^a   Nitschke, Felix ^c   Minassian, Berge A ^c,d   Cingolani, Gino ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

ACTIVE SITE; QUATERNARY STRUCTURE; STRUCTURAL METHODS; STRUCTURAL MODELING;

BIOLOGY;

GLUCOSE; GLYCOGEN; LAFORIN; PHOSPHATASE; UNCLASSIFIED DRUG; EPM2A PROTEIN, HUMAN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SUBSTRATE COMPLEX; GLYCOGEN METABOLISM; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PROTEIN MULTIMERIZATION;

CATALYTIC DOMAIN; HUMANS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84929120501     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.627406     Document Type: Article

References (49)

1. Lafora, G., and Glick, G. (1911) Beitrag zur histopathologie del myoklonischen epilepsie. Z. Ges. Neurol. Psychiatr. 6, 1-14
2. Nitschke, F., Wang, P., Schmieder, P., Girard, J.M., Awrey, D. E., Wang, T., Israelian, J., Zhao, X., Turnbull, J., Heydenreich, M., Kleinpeter, E., Steup, M., and Minassian, B.A. (2013) Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora disease. Cell Metab. 17, 756-767
3. Minassian, B.A. (2002) Progressive myoclonus epilepsy with polyglucosan bodies: Lafora disease. Adv. Neurol. 89, 199-210
4. Minassian, B.A., Lee, J.R., Herbrick, J.A., Huizenga, J., Soder, S., Mungall, A.J., Dunham, I., Gardner, R., Fong, C.Y., Carpenter, S., Jardim, L., Satishchandra, P., Andermann, E., Snead, O. C., 3rd, Lopes-Cendes, I., Tsui, L. C., Delgado-Escueta, A.V., Rouleau, G.A., and Scherer, S. W. (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet. 20, 171-174
5. Serratosa, J.M., Gómez-Garre, P., Gallardo, M. E., Anta, B., de Bernabé, D. B., Lindhout, D., Augustijn, P. B., Tassinari, C.A., Malafosse, R.M., Topcu, M., Grid, D., Dravet, C., Berkovic, S. F., and de Córdoba, S. R. (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum. Mol. Genet. 8, 345-352
6. Chan, E.M., Young, E.J., Ianzano, L., Munteanu, I., Zhao, X., Christopoulos, C. C., Avanzini, G., Elia, M., Ackerley, C.A., Jovic, N. J., Bohlega, S., Andermann, E., Rouleau, G.A., Delgado-Escueta, A.V., Minassian, B.A., and Scherer, S. W. (2003) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat. Genet. 35, 125-127
7. Gentry, M.S., Worby, C.A., and Dixon, J.E. (2005) Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc. Natl. Acad. Sci. U.S.A. 102, 8501-8506
8. Singh, S., and Ganesh, S. (2009) Lafora progressive myoclonus epilepsy: a meta-Analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes. Hum. Mutat. 30, 715-723
9. Ganesh, S., Delgado-Escueta, A.V., Sakamoto, T., Avila, M.R., Machado-Salas, J., Hoshii, Y., Akagi, T., Gomi, H., Suzuki, T., Amano, K., Agarwala, K. L., Hasegawa, Y., Bai, D. S., Ishihara, T., Hashikawa, T., Itohara, S., Cornford, E.M., Niki, H., and Yamakawa, K. (2002) Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum. Mol. Genet 11, 1251-1262
10. Turnbull, J., Wang, P., Girard, J.M., Ruggieri, A., Wang, T.J., Draginov, A. G., Kameka, A. P., Pencea, N., Zhao, X., Ackerley, C.A., and Minassian, B.A. (2010) Glycogen hyperphosphorylation underlies lafora body formation. Ann. Neurol. 68, 925-933
11. Hejazi, M., Fettke, J., Kötting, O., Zeeman, S. C., and Steup, M. (2010) The laforin-like dual-specificity phosphatase SEX4 from Arabidopsis thaliana hydrolyses both C6-And C3-phosphate esters introduced by starch-related dikinases and thereby affects phase transition of α-glucans. Plant Physiol. 152, 711-722
12. Tagliabracci, V. S., Heiss, C., Karthik, C., Contreras, C.J., Glushka, J., Ishihara, M., Azadi, P., Hurley, T. D., DePaoli-Roach, A.A., and Roach, P.J. (2011) Phosphate incorporation during glycogen synthesis and Lafora disease. Cell Metab. 13, 274-282
13. Tagliabracci, V. S., Turnbull, J., Wang, W., Girard, J.M., Zhao, X., Skurat, A.V., Delgado-Escueta, A.V., Minassian, B.A., Depaoli-Roach, A.A., and Roach, P.J. (2007) Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proc. Natl. Acad. Sci. U.S.A. 104, 19262-19266
14. Gentry, M.S., Dowen, R. H., 3rd, Worby, C.A., Mattoo, S., Ecker, J.R., and Dixon, J.E. (2007) The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease. J. Cell Biol. 178, 477-488
15. Lokareddy, R.K., Bhardwaj, A., and Cingolani, G. (2013) Atomic structure of dual-specificity phosphatase 26, a novel p53 phosphatase. Biochemistry 52, 938-948
16. Worby, C.A., Gentry, M.S., and Dixon, J.E. (2006) Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates. J. Biol. Chem. 281, 30412-30418
17. Sankhala, R.S., Lokareddy, R.K., and Cingolani, G. (2014) Structure of human PIR1, an atypical dual-specificity phosphatase. Biochemistry 53, 862-871
18. Koksal, A.C., and Cingolani, G. (2011) Dimerization of vaccinia virus VH1 is essential for dephosphorylation of STAT1 at tyrosine 701. J. Biol. Chem. 286, 14373-14382
19. Olia, A. S., Bhardwaj, A., Joss, L., Casjens, S., and Cingolani, G. (2007) Role of gene 10 protein in the hierarchical assembly of the bacteriophage P22 portal vertex structure. Biochemistry 46, 8776-8784
20. Bhardwaj, A., Olia, A. S., Walker-Kopp, N., and Cingolani, G. (2007) Domain organization and polarity of tail needle GP26 in the portal vertex structure of bacteriophage P22. J. Mol. Biol. 371, 374-387
21. Koksal, A.C., Nardozzi, J.D., and Cingolani, G. (2009) Dimeric quaternary structure of the prototypical dual specificity phosphatase VH1. J. Biol. Chem. 284, 10129-10137
22. Nardozzi, J., Wenta, N., Yasuhara, N., Vinkemeier, U., and Cingolani, G. (2010) Molecular basis for the recognition of phosphorylated STAT1 by importin α5. J. Mol. Biol. 402, 83-100
23. Schuck, P. (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78, 1606-1619
24. Semenyuk, A.V., and Svergun, D. I. (1991) GNOM-A program package for small-Angle scattering data processing. J. Appl. Crystallogr. 24, 537-540
25. Svergun, D. I. (1999) Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J. 76, 2879-2886
26. Wriggers, W. (2010) Using Situs for the integration of multi-resolution structures. Biophys. Rev. 2, 21-27
27. Birmanns, S., Rusu, M., and Wriggers, W. (2011) Using Sculptor and Situs for simultaneous assembly of atomic components into low-resolution shapes. J. Struct. Biol. 173, 428-435
28. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D.M., Meng, E. C., and Ferrin, T. E. (2004) UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612
29. Afonine, P. V., Headd, J.J., Terwilliger, T. C., and Adams, P. D. (2013) New tool: phenix.real-space-refine. Comput. Crystallogr. Newslett. 4, 43-44
30. Svergun, D. I., Barberato, C., and Koch, M.H.J. (1995) CRYSOL-A program to evaluate x-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Crystallogr. 28, 768-773
31. Otwinowski, Z., and Minor, W. (1997) Processing of x-ray diffraction data collected in Oscillation mode. Methods Enzymol. 276, 307-326
32. Terwilliger, T. C., Dimaio, F., Read, R.J., Baker, D., Bunkóczi, G., Adams, P. D., Grosse-Kunstleve, R.W., Afonine, P. V., and Echols, N. (2012) phenix. mr-rosetta: molecular replacement and model rebuilding with Phenix and Rosetta. J. Struct. Funct. Genomics 13, 81-90
33. Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J.J., Hung, L. W., Kapral, G.J., Grosse-Kunstleve, R.W., McCoy, A.J., Moriarty, N. W., Oeffner, R., Read, R.J., Richardson, D.C., Richardson, J.S., Terwilliger, T. C., and Zwart, P.H. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221
34. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132
35. Minassian, B.A., Andrade, D.M., Ianzano, L., Young, E.J., Chan, E., Ackerley, C.A., and Scherer, S. W. (2001) Laforin is a cell membrane and endoplasmic reticulum-Associated protein tyrosine phosphatase. Ann. Neurol. 49, 271-275
36. Christiansen, C., Abou Hachem, M., Janecek, S., Viksø-Nielsen, A., Blennow, A., and Svensson, B. (2009) The carbohydrate-binding module family 20-diversity, structure, and function. FEBS J. 276, 5006-5029
37. Meekins, D.A., Raththagala, M., Husodo, S., White, C.J., Guo, H. F., Kötting, O., Vander Kooi, C. W., and Gentry, M.S. (2014) Phosphoglucanbound structure of starch phosphatase Starch Excess4 reveals the mechanism for C6 specificity. Proc. Natl. Acad. Sci. U.S.A. 111, 7272-7277
38. Lee, J. O., Yang, H., Georgescu, M.M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J.E., Pandolfi, P., and Pavletich, N. P. (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323-334
39. Jackson, M.D., and Denu, J.M. (2001) Molecular reactions of protein phosphatases-insights from structure and chemistry. Chem. Rev. 101, 2313-2340
40. Roy, A., Kucukural, A., and Zhang, Y. (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725-738
41. Sorimachi, K., Le Gal-Coëffet, M. F., Williamson, G., Archer, D. B., and Williamson, M.P. (1997) Solution structure of the granular starch binding domain of Aspergillus niger glucoamylase bound to α-cyclodextrin. Structure 5, 647-661
42. Sánchez-Martín, P., Raththagala, M., Bridges, T. M., Husodo, S., Gentry, M.S., Sanz, P., and Romá-Mateo, C. (2013) Dimerization of the glucan phosphatase laforin requires the participation of cysteine 329. PLoS One 8, e69523
43. Xiao, J., Engel, J.L., Zhang, J., Chen, M.J., Manning, G., and Dixon, J.E. (2011) Structural and functional analysis of PTPMT1, a phosphatase required for cardiolipin synthesis. Proc. Natl. Acad. Sci. U.S.A. 108, 11860-11865
44. Dukhande, V. V., Rogers, D.M., Romá-Mateo, C., Donderis, J., Marina, A., Taylor, A. O., Sanz, P., and Gentry, M.S. (2011) Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. PLoS One 6, e24040
45. Liu, Y., Wang, Y., Wu, C., Liu, Y., and Zheng, P. (2006) Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3β phosphorylation, and Wnt signaling. J. Biol. Chem. 281, 34768-34774
46. Dubey, D., and Ganesh, S. (2008) Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy. Hum. Mol. Genet. 17, 3010-3020
47. Wang, J., Stuckey, J.A., Wishart, M.J., and Dixon, J.E. (2002) A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J. Biol. Chem. 277, 2377-2380
48. DePaoli-Roach, A.A., Contreras, C.J., Segvich, D.M., Heiss, C., Ishihara, M., Azadi, P., and Roach, P.J. (2014) Glycogen phosphomonoester distribution in mouse models of the progressive myoclonic epilepsy, Lafora disease. J. Biol. Chem. 290, 841-850
49. Gayarre, J., Duran-Trío, L., Criado Garcia, O., Aguado, C., Juana-López, L., Crespo, I., Knecht, E., Bovolenta, P., and Rodríguez de Córdoba, S. (2014) The phosphatase activity of laforin is dispensable to rescue Epm2a-/-mice from Lafora disease. Brain 137, 806-818